World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
11061
World Ranking
2883
National Ranking
1358

Sang-Moo Kang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sang-Moo Kang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 257 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sang-Moo Kang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sang-Moo Kang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sang-Moo Kang is affiliated with Georgia State University in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, focusing extensively on subfields such as Epidemiology, Immunology, Infectious Diseases, Pulmonary and Respiratory Medicine, and Genetics.

The scientist's work covers several key topics, including:

  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Immune Response and Inflammation
  • SARS-CoV-2 and COVID-19 Research
  • Neonatal Respiratory Health Research

Sang-Moo Kang has contributed recent publications across notable journals. Some of the recent papers include:

  • Commensal epitopes drive differentiation of colonic T regs, 2020, published in Science Advances
  • Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains, 2021, published in Proceedings of the National Academy of Sciences
  • Lactic Acid Bacteria Isolated From Korean Kimchi Activate the Vitamin D Receptor-autophagy Signaling Pathways, 2020, published in Inflammatory Bowel Diseases
  • An Update on mRNA-Based Viral Vaccines, 2021, published in Vaccines
  • Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle, 2022, published in PLoS Pathogens

Frequent coauthors collaborating with Sang-Moo Kang include:

  • Ki-Hye Kim
  • Noopur Bhatnagar
  • Bao-Zhong Wang
  • Subbiah Jeeva
  • Bo Ryoung Park

Sang-Moo Kang's work appears frequently in several publication venues, notably:

  • Vaccines
  • The Journal of Immunology
  • Virology
  • Vaccine
  • Scientific Reports

Best Publications

  • Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

    Fu-Shi Quan;Chunzi Huang;Richard W. Compans;Sang-Moo Kang

  • Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

    Yeu-Chun Kim;Fu-Shi Quan;Richard W. Compans;Sang-Moo Kang

  • Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.

    Lei Deng;Teena Mohan;Timothy Z. Chang;Gilbert X. Gonzalez

  • Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity.

    Min-Kyung Park;Min-Kyung Park;Vu Ngo;Young-Man Kwon;Young-Tae Lee

  • Influenza virus-like particles containing M2 induce broadly cross protective immunity.

    Jae Min Song;Bao Zhong Wang;Kyoung Mi Park;Nico van Rooijen

  • Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

    Min-Chul Kim;Min-Chul Kim;Jae-Min Song;Eunju O;Young-Man Kwon

  • Influenza vaccines based on virus-like particles.

    Sang-Moo Kang;Jae-Min Song;Fu-Shi Quan;Richard W Compans

  • Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization

    Fu-Shi Quan;Richard W. Compans;Huan H. Nguyen;Sang-Moo Kang

  • Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses

    Bao-Zhong Wang;Fu-Shi Quan;Sang-Moo Kang;Jadranka Bozja

  • Immunology and efficacy of MF59-adjuvanted vaccines.

    Eun-Ju Ko;Sang-Moo Kang

  • Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus

    Jae-Min Song;Nico Van Rooijen;Jadranka Bozja;Richard W. Compans

  • Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice

    Fu-Shi Quan;Yonghwan Kim;Sujin Lee;Hong Yi

  • Improved influenza vaccination in the skin using vaccine coated-microneedles

    Yeu Chun Kim;Fu-Shi Quan;Dae-Goon Yoo;Richard W. Compans

  • Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles

    Sang-Moo Kang;Dae-Goon Yoo;Aleksandr S. Lipatov;Jae-Min Song

  • New vaccines against influenza virus

    Young Tae Lee;Ki Hye Kim;Eun Ju Ko;Yu Na Lee

  • Enhanced Memory Responses to Seasonal H1N1 Influenza Vaccination of the Skin with the Use of Vaccine-Coated Microneedles

    Yeu-Chun Kim;Fu-Shi Quan;Dae-Goon Yoo;Richard W. Compans

  • Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization

    Fu-Shi Quan;Yeu-Chun Kim;Aswani Vunnava;Dae-Goon Yoo

  • Stability of influenza vaccine coated onto microneedles

    Hyo-Jick Choi;Dae-Goon Yoo;Brian J. Bondy;Fu-Shi Quan;Fu-Shi Quan

  • Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.

    Fu-Shi Quan;Yeu-Chun Kim;Yeu-Chun Kim;Richard W. Compans;Mark R. Prausnitz

  • Transcutaneous immunization with inactivated influenza virus induces protective immune responses.

    Ioanna Skountzou;Fu-Shi Quan;Joshy Jacob;Richard W. Compans

  • Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

    Hye Suk Hwang;Young-Man Kwon;Jong Seok Lee;Si-Eun Yoo

Frequent Co-Authors

Richard W. Compans
Richard W. Compans Emory University
Min Chul Kim
Min Chul Kim Gyeongsang National University
Mark R. Prausnitz
Mark R. Prausnitz Georgia Institute of Technology
Martin L. Moore
Martin L. Moore Emory University
Qizhi Yao
Qizhi Yao Baylor College of Medicine
Young-Mi Go
Young-Mi Go Emory University
Dean P. Jones
Dean P. Jones Emory University
Chang-Seon Song
Chang-Seon Song Konkuk University
Andrew T. Gewirtz
Andrew T. Gewirtz Georgia State University
Nico van Rooijen
Nico van Rooijen Vrije Universiteit Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career paths. Many students start with nursing, and there are excellent options for beginners. If you’re not currently a nurse, consider online nursing programs for non nurses that offer flexibility and foundational knowledge to enter the field quickly.

For faster entry into nursing, accelerated nursing programs provide an efficient path to earning a Bachelor of Science in Nursing (BSN). These programs cater to students who already hold a degree in another area, helping them transition smoothly into healthcare roles.

Alternatively, becoming a Licensed Practical Nurse (LPN) is a valuable step toward patient care and can complement immunology studies. To find suitable options, explore which lpn programs are easiest to get into, enabling quick access to practical experience in clinical settings.

For advanced practice, many lean toward becoming a Nurse Practitioner. Discovering what is the easiest np program can help you identify programs that balance accessibility with quality education, broadening your impact in immunology-related fields.

Best Scientists Citing Sang-Moo Kang

Trending Scientists

Recently Published Articles